Deaths from falls among Americans over 65 have more than tripled in the past 3 decades, raising alarm among geriatric experts and fueling debate about the role of prescription drugs, HealthLeaders September 15 reports. The…
Artificial intelligence (AI) is poised to overhaul drug development, with DeepMind CEO Demis Hassabis predicting that discovery timelines could shrink from more than a decade to just months. In a September 13 article from the…
Startups selling artificial intelligence (AI) tools to hospitals are putting money on the line, offering guaranteed returns in a bid to win business from Epic and other entrenched vendors, Modern Healthcare September 16 reports. Several…